NCT06077903View on ClinicalTrials.gov

GT101 Injection in the Treatment of Metastatic/Recurrent Advanced Solid Tumors

EARLY_PHASE1RecruitingINTERVENTIONAL

Enrollment

20

Participants

Timeline

Start Date

July 5, 2021

Primary Completion Date

July 31, 2025

Study Completion Date

July 31, 2025

Conditions

Adult

Interventions

BIOLOGICAL

GT101

Autologous tumor infiltrating lymphocyte injection

Trial Locations (1)

450000

RECRUITING

The First Affiliated Hospital of Zhengzhou University, Zhengzhou

Sponsors

Lead Sponsor

Grit Biotechnology

All Listed Sponsors

lead

Grit Biotechnology

INDUSTRY